HCP (HCP) Hits New 12-Month Low at $23.57
HCP, Inc. (NYSE:HCP) reached a new 52-week low during trading on Wednesday . The company traded as low as $23.57 and last traded at $23.72, with a volume of 3902300 shares trading hands. The stock had previously closed at $23.64.
A number of research firms recently commented on HCP. BMO Capital Markets set a $25.00 target price on shares of HCP and gave the company a “hold” rating in a research report on Monday. Robert W. Baird decreased their target price on shares of HCP from $29.00 to $26.00 and set a “neutral” rating for the company in a research report on Friday, January 5th. Zacks Investment Research cut shares of HCP from a “hold” rating to a “sell” rating in a research report on Tuesday, January 2nd. ValuEngine cut shares of HCP from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Finally, JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and set a $29.00 target price for the company in a research report on Friday, December 15th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $30.14.
The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 1.17. The stock has a market capitalization of $11,127.25, a P/E ratio of 21.02, a PEG ratio of 2.66 and a beta of 0.38.
A number of institutional investors have recently modified their holdings of HCP. Cohen & Steers Inc. increased its stake in HCP by 26.6% during the 3rd quarter. Cohen & Steers Inc. now owns 35,762,597 shares of the real estate investment trust’s stock valued at $995,273,000 after purchasing an additional 7,524,081 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of HCP by 475.0% in the third quarter. Principal Financial Group Inc. now owns 4,284,833 shares of the real estate investment trust’s stock worth $119,248,000 after acquiring an additional 3,539,670 shares during the period. Daiwa Securities Group Inc. increased its stake in shares of HCP by 15.4% in the third quarter. Daiwa Securities Group Inc. now owns 12,243,041 shares of the real estate investment trust’s stock worth $340,724,000 after acquiring an additional 1,632,319 shares during the period. Royal Bank of Canada increased its stake in shares of HCP by 353.7% in the second quarter. Royal Bank of Canada now owns 1,826,053 shares of the real estate investment trust’s stock worth $58,362,000 after acquiring an additional 1,423,582 shares during the period. Finally, Cbre Clarion Securities LLC increased its stake in shares of HCP by 18.1% in the second quarter. Cbre Clarion Securities LLC now owns 9,223,958 shares of the real estate investment trust’s stock worth $294,798,000 after acquiring an additional 1,413,760 shares during the period. Institutional investors and hedge funds own 90.07% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “HCP (HCP) Hits New 12-Month Low at $23.57” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://theolympiareport.com/2018/01/19/hcp-hcp-hits-new-12-month-low-at-23-57.html.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.